BBNX (BBNX) Stock Price & Analysis
BBNX (BBNX) rose 0.00% to USD 15.85 as of July 26, 2026 at 09:43 UTC, according to Nexqual real-time market data.
BBNX last closed at USD 15.85; the session ranged USD 15.73–16.37 on volume of 558,299 shares. Market capitalization is —, with a 52-week range of USD 8.8–32.71 (NGM). Source: Nexqual, July 26, 2026 at 09:43 UTC.
Key Statistics (as of July 26, 2026 at 09:43 UTC)
| Price | USD 15.85 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 15.85 |
| Open | USD 15.85 |
| Day Range | USD 15.73 – 16.37 |
| 52-Week Range | USD 8.8 – 32.71 |
| Volume | 558,299 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (BBNX)
Nexqual's technical model rates BBNX "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 26, 2026 at 09:43 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 47.8 (neutral) |
| vs SMA50 | Above (USD 14.25) |
| MACD | 0.6 (positive) |
From BBNX's Latest SEC 10-K Filing (filed 2026-02-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KMTS | Kestra Medical Technologies, Lt | USD 21.06 | ▲ 0.81% |
| CBLL | CeriBell, Inc. | USD 16.91 | ▲ 0.54% |
| MAZE | Maze Therapeutics, Inc. | USD 27.68 | ▼ 2.84% |
| SION | Sionna Therapeutics, Inc. | USD 45.7 | ▲ 1.49% |
| BCAX | Bicara Therapeutics Inc. | USD 27.02 | ▼ 3.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 09:43 UTC. This page is informational and not investment advice.